Monday, February 3, 2014

Give the data to the people, says Krumholz

In the New York Times, Harlan Krumholz writes about Johnson and Johnson's announcement that it is opening up its clinical trial data:

"There are many benefits to this kind of sharing. It honors the contributions of the subjects and scientists who participated in the research. It is proof that an organization, whether it is part of industry or academia, wants to play a role as a good global citizen. It demonstrates that the organization has nothing to hide. And it enables scientists to use the data to learn new ways to help patients. Such an approach can even teach a company like Johnson & Johnson something it didn’t know about its own products."

No comments:

Post a Comment